https://bit.ly/UWPhoneStudy Are you interested in contributing your time towards research on accessible home-based healthcare screening? We are researchers at UW in the Ubicomp Lab, and we’ve developed a new type of test strip for biomarker reading that works directly with your smartphone. These biomarkers can indicate risk...
This study is testing an investigational drug called frexalimab in adolescents and adults age 12-35 years old with newly diagnosed type 1 diabetes who are on insulin therapy (adults age 18-35 will be enrolled first, followed by 12 to 21-year-olds later in the study). You will...
For people age 12 – 35 years who have been diagnosed with type 1 diabetes in the past 3 months, this study tests two JAK inhibitors (abrocitinib and ritlecitinib) to see if either or both can preserve insulin production. TrialNet researchers are testing two different JAK...
One in five adolescents and young adults with type 1 diabetes exhibit disordered eating behaviors (DEB)—nearly twice the rate among healthy peers and affecting females more than males. Several studies show that those with DEB have worse health outcomes. Researchers at the Seattle Children’s Hospital want...
In recent years a new group of medications to control blood sugar have been approved by the FDA. These “GLP1-RA” drugs have been proven to work well on lowering blood sugars and improving the health of patients with Type 2 Diabetes. Early data also indicates...
The EN 21-01 study is testing a new investigational medication, called NRD135S.E1, to see if it is helpful and safe for patients with painful diabetic peripheral neuropathy. NRD135S.E1 showed a decrease in pain after 3 weeks of study treatment when compared to a placebo in...
This research study is a collaboration between the University of Wyoming and the University of Washington. We are asking you to complete this survey because you are over the age of 65 years. The purpose of this survey is to better understand various health behaviors and...
Identify patients and families with novel rare/atypical forms of diabetes and characterize the underlying molecular mechanisms Outreach and inclusivity of minority and underrepresented populations Perform genetic and phenotypic characterization of participants Construct an access-controlled biorepository and database Make data and biosamples available to the scientific community to advance research...
The UW Medicine Diabetes Institute is the proud home of the COVERED Registry. COVERED stands for Community of Volunteers Engaged in Research to End Diabetes. The goal of this patient registry is to connect people interested in diabetes care with researchers studying diabetes and other...
